N-[5-Chloro-1,2-dihydro-1-(4'-fluorobenzyl)-4-methyl-2-oxopyridin-3-yl]cycloheptanecarboxamide

ID: ALA4475913

PubChem CID: 155537849

Max Phase: Preclinical

Molecular Formula: C21H24ClFN2O2

Molecular Weight: 390.89

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1c(Cl)cn(Cc2ccc(F)cc2)c(=O)c1NC(=O)C1CCCCCC1

Standard InChI:  InChI=1S/C21H24ClFN2O2/c1-14-18(22)13-25(12-15-8-10-17(23)11-9-15)21(27)19(14)24-20(26)16-6-4-2-3-5-7-16/h8-11,13,16H,2-7,12H2,1H3,(H,24,26)

Standard InChI Key:  YAQDFCQBXFQUGB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   36.2206   -3.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2206   -4.0942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9258   -4.4987    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.6311   -4.0942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6311   -3.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9258   -2.8643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9258   -2.0471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3382   -4.5038    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.3400   -2.8705    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.0465   -3.2812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7554   -2.8746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0441   -4.0984    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.6972   -2.0668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2980   -1.5101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4306   -3.3408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1052   -1.6293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2129   -3.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.5103   -2.3377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9258   -5.3159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6335   -5.7245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6293   -6.5427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3362   -6.9512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0449   -6.5426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0423   -5.7212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3348   -5.3164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7531   -6.9502    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.5117   -2.8705    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  4  8  2  0
  5  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 11 13  1  0
 13 14  1  0
 11 15  1  0
 14 16  1  0
 15 17  1  0
 16 18  1  0
 17 18  1  0
  3 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
  1 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475913

    ---

Associated Targets(Human)

CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.89Molecular Weight (Monoisotopic): 390.1510AlogP: 4.91#Rotatable Bonds: 4
Polar Surface Area: 51.10Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.64CX Basic pKa: CX LogP: 4.35CX LogD: 4.35
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.75Np Likeness Score: -1.36

References

1. Gado F, Di Cesare Mannelli L, Lucarini E, Bertini S, Cappelli E, Digiacomo M, Stevenson LA, Macchia M, Tuccinardi T, Ghelardini C, Pertwee RG, Manera C..  (2018)  Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief.,  62  (1): [PMID:29990428] [10.1021/acs.jmedchem.8b00368]

Source